Etzer Darout's
Stock Forecasts
2.38%
1/42 win trades
Price targets by Etzer Darout
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Nurix Therapeutics, Inc. NRIX | 11 months ago | $35 253.89% upside | $20.06 | StreetInsider | Previous targets (0) |
 IGM Biosciences, Inc. IGMS | 11 months ago | $21 1540.62% upside | $9.46 | StreetInsider | Previous targets (0) |
 Protagonist Therapeutics, Inc. PTGX | 11 months ago | $62 10.32% upside | $41.68 | StreetInsider | Previous targets (0) |
 Kymera Therapeutics, Inc. KYMR | 11 months ago | $55 29.19% upside | $44.08 | StreetInsider | Previous targets (0) |
 Jasper Therapeutics, Inc. JSPR | 11 months ago | $63 2134.04% upside | $21.53 | StreetInsider | Previous targets (0) |
 Tourmaline Bio, Inc. TRML | 11 months ago | $50 123.51% upside | $24.03 | StreetInsider | Previous targets (0) |
 Q32 Bio Inc. QTTB | 11 months ago | $64 3416.48% upside | $23.69 | StreetInsider | Previous targets (0) |
 Merus N.V. MRUS | 11 months ago | $95 47.90% upside | $48.53 | StreetInsider | |
 Acrivon Therapeutics, Inc. Common Stock ACRV | 12 months ago | $27 1915.52% upside | $7.92 | StreetInsider | |
 Scholar Rock Holding Corporation SRRK | 12 months ago | $39 26.95% upside | $26.97 | StreetInsider | |
 AstraZeneca PLC AZN | 12 months ago | $88 10.63% upside | $81.19 | StreetInsider | |
 Nuvalent, Inc. NUVL | 12 months ago | $134 78.66% upside | $69.99 | StreetInsider | Previous targets (0) |
 Fate Therapeutics, Inc. FATE | 12 months ago | $5 338.67% upside | $3.37 | StreetInsider | |
 Y-mAbs Therapeutics, Inc. YMAB | 12 months ago | $24 181.35% upside | $15.06 | StreetInsider | |
 CytomX Therapeutics, Inc. CTMX | 12 months ago | $3.68 83.99% upside | $1.09 | StreetInsider | |
 BioNTech SE BNTX | about 1 year ago | $126 12.09% upside | $108.97 | StreetInsider | |
 Novartis AG NVS | about 1 year ago | $120 -4.45% downside | $109.91 | StreetInsider | |
 Exelixis, Inc. EXEL | about 1 year ago | $36 -4.10% downside | $32.56 | StreetInsider | Previous targets (0) |
 C4 Therapeutics, Inc. CCCC | about 1 year ago | $20 629.92% upside | $6.87 | StreetInsider | Previous targets (0) |
 Terns Pharmaceuticals, Inc. TERN | about 1 year ago | $26 312.03% upside | $8.96 | TheFly | |
 Xencor, Inc. XNCR | over 1 year ago | $32 313.43% upside | $20.9 | StreetInsider | Previous targets (0) |
 MacroGenics, Inc. MGNX | over 1 year ago | $8 429.80% upside | $14.67 | TheFly | Previous targets (0) |
 Genmab A/S GMAB | over 1 year ago | $48 101.51% upside | $29.16 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Olga Smolentseva
Bryan Garnier & Co Ltd
100%
win rate
Covering:
Andrew Ang
UBS
100%
win rate
Covering:
Daina Graybosch
Leerink Partners
50%
win rate
Covering:
Emmanuel Papadakis
Deutsche Bank
28.57%
win rate
Christopher Liu
Leerink Partners
25%
win rate